Nigel Stapleton

Nigel Stapleton, PhD, currently serves as the VP of Business Development and Head of Europe at Mabion S.A., a company specializing in biosimilars and CDMO services. With extensive experience in the biopharma sector, Nigel previously held positions as Director of Business Development at KBI Biopharma and International Business Developer at HALIX B.V. Additionally, Nigel managed sales and business development roles at Eurofins Sinensis and Sinensis Life Sciences B.V., while also overseeing operations and R&D at MicroSafe Laboratories and Merck Millipore. Nigel began an academic career with a PhD in immunology from the University of Amsterdam, following a Master's degree in Biology from Wageningen University.